Furthermore, low-risk patients possessed a higher fraction of some tumor-suppressor TILs (such as NK cells activated, Macrophages M1 (Chanmee et al. 2014), and T cells CD4 memory activated (Tay et al. 2021)), associated with improved RFS. This evidence concerns the gene CD4 and neoplasm.